THE COST-EFFECTIVENESS OF CANAGLIFLOZIN COMPARED WITH LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN AND SULFONYLUREA IN FRANCE

被引：1
|
作者：
Troelsgaard, A. [1 ]
Pitcher, A. [2 ]
Granados, D. [3 ]
Hemels, M. [1 ]
Lloyd, A. [2 ]
机构：
[1] Janssen AS, Birkerod, Denmark
[2] IMS Hlth, London, England
[3] Janssen, Paris, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.707
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB85
引用
收藏
页码：A346 / A347
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of sitagliptin compared with sulfonylurea therapy in patients with type 2 diabetes showing inadequately controlled glycosylated hemoglobin with metformin monotherapy: A meta-analysis
    Hou, Liqiong
    Zhao, Tieyun
    Liu, Yunhui
    Zhang, Yiyi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (04) : 1528 - 1536
  • [42] COST-EFFECTIVENESS ANALYSIS OF LINAGLIPTIN VERSUS SULFONYLUREA AS ADD-ON TREATMENT TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN INDONESIA
    Endarti, D.
    Kristin, E.
    Pratiwi, W. R.
    Pinzon, R. T.
    Nugrahaningsih, D. A.
    Yasmina, A.
    Febrinasari, R. P.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [43] Insulin glargine improves health related quality of life in patients with type 2 diabetes inadequately controlled on sulfonylurea plus metformin
    Vinik, AI
    Dailey, G
    Zhang, Q
    DIABETOLOGIA, 2005, 48 : A312 - A312
  • [44] DAPAGLIFLOZIN VERSUS SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COLOMBIA: COST-EFFECTIVENESS ANALYSIS
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A172 - A172
  • [45] Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
    Matthew J. Budoff
    Timothy M. E. Davis
    Alexandra G. Palmer
    Robert Frederich
    David E. Lawrence
    Jie Liu
    Ira Gantz
    Giuseppe Derosa
    Diabetes Therapy, 2021, 12 : 1279 - 1297
  • [46] Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
    Budoff, Matthew J.
    Davis, Timothy M. E.
    Palmer, Alexandra G.
    Frederich, Robert
    Lawrence, David E.
    Liu, Jie
    Gantz, Ira
    Derosa, Giuseppe
    DIABETES THERAPY, 2021, 12 (05) : 1279 - 1297
  • [47] SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Abrar, Amjad
    Khan, Shimal
    Rehman, Mehboob Ur
    Jan, Tehmina
    Faisal, Muhammad
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2013, 11 (01): : 3 - 7
  • [48] Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
    Gabriela Vega-Hernandez
    Radek Wojcik
    Max Schlueter
    Diabetes Therapy, 2017, 8 : 513 - 530
  • [49] Efficacy and safety of Sancailianmei Particle compared with acarbose in patients with type 2 diabetes mellitus inadequately controlled with metformin
    Tang, Zhimei
    Chen, Huizhen
    Fang, Wei
    Luo, Yulei
    Wang, Huanping
    Wei, Chenchen
    Xie, Qinwen
    Gao, Yang
    Gan, Huakui
    Zuo, Zhihuang
    Chen, Qi
    Shi, Cuimei
    Zhang, Xinli
    Guo, Jian
    Xiong, Xiaoling
    Yan, Wei
    Yang, Jiao
    Zhang, Xiaoran
    Sung, Lisha
    Chen, Qiu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 9005 - 9016
  • [50] Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
    Vega-Hernandez, Gabriela
    Wojcik, Radek
    Schlueter, Max
    DIABETES THERAPY, 2017, 8 (03) : 513 - 530
12345